R. Clayton Fletcher
2017
In 2017, R. Clayton Fletcher earned a total compensation of $738.1K as Senior Vice President, Business Development and Strategy at Idera Pharmaceuticals, a 15% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $145,908 |
|---|---|
| Option Awards | $182,924 |
| Salary | $386,300 |
| Other | $22,988 |
| Total | $738,120 |
Fletcher received $386.3K in salary, accounting for 52% of the total pay in 2017.
Fletcher also received $145.9K in non-equity incentive plan, $182.9K in option awards and $23K in other compensation.
Rankings
In 2017, R. Clayton Fletcher's compensation ranked 10,368th out of 14,666 executives tracked by ExecPay. In other words, Fletcher earned more than 29.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,368 out of 14,666 | 29th |
Division Manufacturing | 4,021 out of 5,772 | 30th |
Major group Chemicals And Allied Products | 1,422 out of 2,075 | 32nd |
Industry group Drugs | 1,157 out of 1,731 | 33rd |
Industry Biological Products, Except Diagnostic Substances | 208 out of 313 | 34th |
Source: SEC filing on April 25, 2019.
Fletcher's colleagues
We found five more compensation records of executives who worked with R. Clayton Fletcher at Idera Pharmaceuticals in 2017.
2017
Vincent Milano
Idera Pharmaceuticals
Chief Executive Officer
2017
Jonathan Yingling
Idera Pharmaceuticals
Chief Scientific Officer
2017
Joanna Horobin
Idera Pharmaceuticals
Chief Medical Officer
2017
Louis Arcudi
Idera Pharmaceuticals
Chief Financial Officer
2017
John Kirby
Idera Pharmaceuticals